ArticleCancer chemotherapy and pharmacology2024

Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors.

Kadriye Bir Yücel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.